A summary of lymphoma immune checkpoint inhibitor data at EHA 2017
Safety of ponatinib in chronic-phase chronic myeloid leukemia (CML) patients
Michael J. Mauro
UKALL60+: identifying the standard of care for elderly patients with ALL
Double hit lymphoma: a challenge for lymphoma experts
Have novel drugs made stem cell transplantation obsolete?